EUVIMEDEUVIMED entdecken
Crossref

A Modified Sampson–NIH Equation with Improved Accuracy for Estimating Low Levels of Low-Density Lipoprotein-Cholesterol

Maureen Sampson iD, Rafael Zubiran iD, Anna Wolska iD, Jeffrey W Meeusen, Leslie J Donato, Allan S Jaffe iD, Giorgio E M Melloni, Robert P Giugliano, Marc S Sabatine, Nicholas A Marston iD, Alan T Remaley iD

Clinical Chemistry · 04.11.2025 · 71 (11) · 1125-1137

DOI: 10.1093/clinchem/hvaf073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, online erschienen am 09.07.2025. Verfasst von Maureen Sampson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, United States. Hauptthemen laut MEDLINE: Cholesterol, LDL. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Intramural Research Program of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health, Leducq Foundation for Cardiovascular Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular guidelines have long recommended low-density lipoprotein-cholesterol (LDL-C) as the primary target for lipid-lowering therapy. Recent guidelines have emphasized the importance of achieving low LDL-C levels; hence, the accurate measurement of low LDL-C is increasingly clinically relevant.

Methods

Using lipid panel test results from the Mayo Clinic (n = 24 590) and the FOURIER clinical trial of evolocumab (n = 9605), the following modified Sampson equation was developed by least-squares regression to match LDL-C (mg/dL) by the β-quantification reference method, by combining terms into non High Density Lipoprotein Cholesterol (nonHDLC = Total Cholesterol – High Density Lipoprotein Cholesterol) and forcing the coefficient to be one: Results The modified Sampson equation demonstrated significant improvement in its concordance to the reference method compared to other equations (the Lin Concordance Correlation Coefficient 0.992, P < 0.001). By overall kappa analysis, it showed the best agreement to the reference method at the 55 mg/dL cutpoint (1.4 mmol/L, 0.98 [P < 0.001], Sampson–NIH: 0.96, Martin–Hopkins: 0.96, Friedewald: 0.94) and the 70 mg/dL cutpoint (1.8 mmol/L, 0.97 [P < 0.001], Sampson–NIH: 0.94, Martin–Hopkins: 0.95, Friedewald: 0.92). The false classification rate of the modified Sampson equation was also significantly lower compared to the other equations at 55 mg/dL (15%, [P < 0.001], Sampson–NIH: 29%, Martin–Hopkins: 28%, Friedewald: 37%) and 70 mg/dL (18%, [P < 0.001]; Sampson–NIH: 30%, Martin–Hopkins: 28.%, Friedewald: 34%). The new equation increases the percentage of correctly classified patients with low LDL-C by approximately 10% to 20% over the other equations based on its net reclassification index.

Conclusions

The modified Sampson equation shows improved accuracy compared to other equations for low LDL-C. It more accurately identifies high-risk patients, who are not at their LDL-C goals and could benefit from more intensive lipid-lowering therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesterol, LDLHumansMaleFemaleMiddle AgedAntibodies, Monoclonal, HumanizedAnticholesteremic AgentsLeast-Squares Analysis

Substanzen

Cholesterol, LDLevolocumabAntibodies, Monoclonal, HumanizedAnticholesteremic Agents

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, United States.
  • Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

ORCID-Profile: Maureen Sampson, Rafael Zubiran, Anna Wolska, Allan S Jaffe, Nicholas A Marston, Alan T Remaley

Förderung

  • Intramural Research Program of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health
  • Leducq Foundation for Cardiovascular Research

Zitieren

APA

Sampson, M., Zubiran, R., Wolska, A., Meeusen, J. W., Donato, L. J., Jaffe, A. S., Melloni, G. E. M., Giugliano, R. P., Sabatine, M. S., Marston, N. A., & Remaley, A. T. (2025). A Modified Sampson–NIH Equation with Improved Accuracy for Estimating Low Levels of Low-Density Lipoprotein-Cholesterol. Clinical Chemistry, 71(11), 1125-1137. https://doi.org/10.1093/clinchem/hvaf073

Vancouver

Sampson M, Zubiran R, Wolska A, Meeusen JW, Donato LJ, Jaffe AS, et al. A Modified Sampson–NIH Equation with Improved Accuracy for Estimating Low Levels of Low-Density Lipoprotein-Cholesterol. Clinical Chemistry. 2025;71(11):1125-1137. doi:10.1093/clinchem/hvaf073

BibTeX
@article{Sampson2025,
  author = {Sampson, Maureen and Zubiran, Rafael and Wolska, Anna and Meeusen, Jeffrey W and Donato, Leslie J and Jaffe, Allan S and Melloni, Giorgio E M and Giugliano, Robert P and Sabatine, Marc S and Marston, Nicholas A and Remaley, Alan T},
  title = {A Modified Sampson–NIH Equation with Improved Accuracy for Estimating Low Levels of Low-Density Lipoprotein-Cholesterol},
  journal = {Clinical Chemistry},
  year = {2025},
  volume = {71},
  number = {11},
  pages = {1125--1137},
  doi = {10.1093/clinchem/hvaf073}
}
Kostenlos starten →